Filing Details
- Accession Number:
- 0001104659-22-064786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-25 19:00:27
- Reporting Period:
- 2022-05-24
- Accepted Time:
- 2022-05-25 19:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326190 | Altimmune Inc. | ALT | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428764 | David Drutz | C/O Altimmune, Inc 910 Clopper Road, Suite 201S Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2022-05-24 | 1,200 | $4.50 | 19,012 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.0001 | 333 | Indirect | See Footnote |
Footnotes
- Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.
Billionaire Hedge Funds
